Production (Stage)
Kiora Pharmaceuticals, Inc.
KPRX
$3.05
-$0.03-0.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.19M | -4.22M | -3.41M | -2.22M | 13.45M |
| Total Depreciation and Amortization | 19.60K | 17.40K | 14.20K | 17.90K | 16.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 399.90K | -149.60K | 1.02M | 198.10K | 163.20K |
| Change in Net Operating Assets | -930.70K | 2.10M | 3.30M | -1.73M | -7.80K |
| Cash from Operations | -2.70M | -2.25M | 920.10K | -3.73M | 13.62M |
| Capital Expenditure | -- | 45.00K | 0.00 | -51.30K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.67M | 437.70K | -1.92M | -21.17M | -- |
| Cash from Investing | 2.67M | 482.70K | -1.92M | -21.22M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 249.40K | 16.44M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 1.10K | -1.19M |
| Cash from Financing | -- | 0.00 | 0.00 | 250.50K | 15.25M |
| Foreign Exchange rate Adjustments | 10.10K | -75.50K | 62.30K | 7.00K | -51.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.30K | -1.85M | -938.00K | -24.70M | 28.82M |